Indoline derivatives as ddr1 and ddr2 inhibitors

A compound of formula (I)

• wherein
• R1 is H or —(C1-C4)alkyl;
• L is —CH2;
• L1 is selected from the group consisting of —C(O)NH— and —NHC(O)—;
• Hy is a monocyclic heteroaryl optionally substituted by one or more groups selected from —(CH2)nNR4R5, —C(O)NR4R5, —(C1-C4)alkyl, —NR4(CO)R5, —(C1-C4)alkylene-O—(C1-C4)alkyl and —(C4-C7)heterocycloalkyl optionally substituted by one or more groups selected from —(C1-C4)alkyl and oxo;
• n is 0, 1 or 2;
• R4 is H or —(C1-C4)alkyl;
• R5 is H or is selected from the group consisting of (C3-C7)cycloalkyl, —(C1-C4)alkyl and heteroaryl optionally substituted by one or more groups selected from —(C1-C4)alkyl, —(C1-C4)alkylene-NR1R4 and —(C1-C4)alkylene-O—(C1-C4)alkyl;
• X is
• wherein R2 is selected from the group consisting of —(C1-C4)alkyl, —O(C1-C4)haloalkyl, a halogen atoms atom, —(C1-C4)haloalkyl, —(C3-C7)cycloalkyl and —O(C3-C7)cycloalkyl;
• R3 is H or is selected from the group consisting of —O(C1-C4)alkyl, heteroaryl optionally substituted by one or more —(C1-C4)alkyl, and (C4-C7)heterocycloalkyl-(C1-C4)alkylene-, wherein said —(C4-C7)heterocycloalkyl is optionally substituted by one or more groups selected from —(C1-C4)alkyl and —O(C1-C4)alkyl;
• or a pharmaceutically acceptable salt thereof.